Insider Trading History of Saad Mark E


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Saad Mark E since year 2005. The trader's CIK number is 1295913. At the time of the last reporting, Saad Mark E was the Officer of Axsome Therapeutics, Inc. . (stock ticker symbol AXSM). See this page for all insider trading activities at Axsome Therapeutics, Inc. .

Note that in the past Saad Mark E also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Saad Mark E since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-05-23 AXSM Axsome Therapeutics, Inc. Buy 3,500 22.33 78,155
2012-03-14 CYTX Cytori Therapeutics, Inc. Buy 10,000 2.54 25,450
2011-08-12 CYTX Cytori Therapeutics, Inc. Buy 6,500 3.12 20,299
2010-05-21 CYTX Cytori Therapeutics, Inc. Buy 6,000 4.29 25,740
2008-08-12 CYTX Cytori Therapeutics, Inc. Buy 15,000 6.69 100,305
2006-09-05 CYTX Cytori Therapeutics, Inc. Buy 1,850 5.08 9,396
2006-09-01 CYTX Cytori Therapeutics, Inc. Buy 1,550 5.31 8,224
2006-08-31 CYTX Cytori Therapeutics, Inc. Buy 750 5.47 4,106
2006-08-29 CYTX Cytori Therapeutics, Inc. Buy 800 5.22 4,176
2006-08-30 CYTX Cytori Therapeutics, Inc. Buy 750 5.42 4,067
2006-08-25 CYTX Cytori Therapeutics, Inc. Buy 800 4.99 3,993
2006-08-28 CYTX Cytori Therapeutics, Inc. Buy 800 5.20 4,157
2006-08-23 CYTX Cytori Therapeutics, Inc. Buy 850 4.28 3,637
2006-08-24 CYTX Cytori Therapeutics, Inc. Buy 850 4.62 3,928
2006-08-21 CYTX Cytori Therapeutics, Inc. Buy 883 4.52 3,991
2006-08-22 CYTX Cytori Therapeutics, Inc. Buy 1,617 4.27 6,907

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Saad Mark E (Officer of Axsome Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.